ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth (Q34438128)

2 August 2017

ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth (English)

1 reference

2 August 2017

hepatocellular carcinoma

1 reference

Lu Zheng

1

1 reference

2 August 2017

Ping Liang

2

1 reference

2 August 2017

Jing Li

3

1 reference

2 August 2017

Xiao-bing Huang

4

1 reference

2 August 2017

Shi-cheng Liu

5

1 reference

2 August 2017

Hong-zhi Zhao

6

1 reference

2 August 2017

Ke-qiang Han

7

1 reference

2 August 2017

Zheng Wang

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

25 September 2012

1 reference

2 August 2017

1 reference

2 August 2017

7

1 reference

2 August 2017

9

1 reference

2 August 2017

e45412

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

start time

25 September 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Nuclear factor-kappaB in development, prevention, and therapy of cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

COMMD proteins, a novel family of structural and functional homologs of MURR1

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

siRNA Selection Server: an automated siRNA oligonucleotide prediction server

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

IkappaB kinases: key regulators of the NF-kappaB pathway

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Screening and identification for cDNA of differentially expressed genes in human primary hepatocellular carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Activators and target genes of Rel/NF-kappaB transcription factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Epidemiology of primary liver cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3458015

BC047440 overexpression is a risk factor for tumor invasion and poor prognosis in hepatocellular carcinoma

27 October 2018

1 reference

12 December 2020

Epidemiology of hepatocellular carcinoma

1 reference

12 December 2020

[Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma]

1 reference

12 December 2020

Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy

1 reference

12 December 2020

[Therapy response of liver tumors after selective internal radiation therapy]

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0045412

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference